{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:36:41Z","timestamp":1783528601147,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ijcard.2015.05.023","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T03:38:08Z","timestamp":1431056288000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Ticagrelor-related gout: An underestimated side effect"],"prefix":"10.1016","volume":"192","author":[{"given":"Nixiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.05.023_bb0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijcard.2014.11.131","article-title":"Prasugrel and ticagrelor compared to clopidogrel in non-st-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: certainties and uncertainties","volume":"181","author":"De Servi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0010","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijcard.2015.03.414","article-title":"Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: a prospective randomized study","volume":"187","author":"Bonello","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2015.03.417","article-title":"Ticagrelor related dyspnea in patients with acute coronary syndromes: incidence and implication on ticagrelor withdrawn","volume":"187","author":"Sanchez-Galian","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijcard.2014.11.054","article-title":"Ticagrelor-related dyspnea: an underestimated and poorly managed event?","volume":"179","author":"Lombardi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0025","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.ijcard.2014.07.216","article-title":"First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea","volume":"176","author":"Wu","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2014.02.028","article-title":"Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients","volume":"173","author":"Gaubert","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0040","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.11.056","volume":"57","author":"Scirica","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2014.12.162","article-title":"Life-threatening complete atrioventricular block associated with ticagrelor therapy","volume":"182","author":"Goldberg","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2015.04.198","article-title":"Side effects of ticagrelor: sinus node dysfunction with ventricular pause","volume":"191","author":"Nicol","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0055","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.maturitas.2014.05.001","article-title":"Joints and beyond, epidemiology, clinical features, treatment and co-morbidities","volume":"78","author":"Robinson","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.ijcard.2015.05.023_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2012.05.083","article-title":"Monosodium urate (MSU) crystals increase gout associated coronary heart disease (CHD) risk through the activation of nlrp3 inflammasome","volume":"160","author":"He","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0070","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by azd6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes","volume":"50","author":"Storey","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0075","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1124\/dmd.110.032250","article-title":"Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects","volume":"38","author":"Teng","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/clpt.2011.223","article-title":"Evaluation and characterization of the effects of ticagrelor on serum and urinary uric acid in healthy volunteers","volume":"91","author":"Butler","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0085","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist azd6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physiol.00039.2004","article-title":"Molecular physiology of urate transport","volume":"20","author":"Hediger","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ijcard.2015.05.023_bb0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2015.05.023_bb0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1681\/ASN.2006040415","article-title":"Human renal organic anion transporter 4 operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1523-1755.2003.00710.x","article-title":"Urate transport via human PAH transporter HOAT1 and its gene structure","volume":"63","author":"Ichida","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000074539","article-title":"Human organic anion transporter 3 (HOAT3) can operate as an exchanger and mediate secretory urate flux","volume":"13","author":"Bakhiya","year":"2003","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0115","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1152\/ajprenal.00133.2004","article-title":"Human organic anion transporter mrp4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites","volume":"288","author":"Van Aubel","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.102.037580","article-title":"Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs","volume":"303","author":"Khamdang","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/FJC.0b013e31820eb788","article-title":"Physiological and pharmacological roles of vascular nucleoside transporters","volume":"59","author":"Li","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0130","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/ATVBAHA.106.126714","article-title":"Physiological roles of vascular nucleoside transporters","volume":"27","author":"Loffler","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0135","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","article-title":"Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance","volume":"63","author":"Cattaneo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.023_bb0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","article-title":"Structure and function of xanthine oxidoreductase: where are we now?","volume":"33","author":"Harrison","year":"2002","journal-title":"Free Radic. Biol. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315010426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315010426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T15:24:02Z","timestamp":1566660242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315010426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":28,"alternative-id":["S0167527315010426"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.023","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ticagrelor-related gout: An underestimated side effect","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}